Literature DB >> 22472991

Impact of safety-related regulatory action on drug use in ambulatory care in the Netherlands.

S Piening1, K C Reber, J E Wieringa, S M J M Straus, P A de Graeff, F M Haaijer-Ruskamp, P G M Mol.   

Abstract

The effect of Direct Healthcare Professional Communications (DHPCs) informing health-care providers of serious drug safety issues has been questioned. The aim of this study was to evaluate the impact of DHPCs on drug use.Nationwide dispensing data for the period 2000–2008 for new users of 46 drugs with one or more DHPCs were assessed. Impact on short-term volume of use was evaluated with regression models, and the presence of long-term changes in use was evaluated with interrupted time series analyses incorporating preexisting trends. The short-term prescription level was lower post-DHPC in 28 (48.3%) of 58 cases. Twenty (34.5%) DHPCs resulted in long-term changes in use. A long-term mean reduction in use was observed in 26.7% of cases (95% confidence interval, −15.2 to −38.2%).Long-term changes in use were not significantly related to preexisting trends in use. Although short- and long-term decreases in use were observed after only half and a third of DHPCs, respectively, the decrease was substantial.

Entities:  

Mesh:

Year:  2012        PMID: 22472991     DOI: 10.1038/clpt.2011.308

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  13 in total

1.  The Additional Value of an E-Mail to Inform Healthcare Professionals of a Drug Safety Issue: A Randomized Controlled Trial in the Netherlands.

Authors:  Sigrid Piening; Pieter A de Graeff; Sabine M J M Straus; Flora M Haaijer-Ruskamp; Peter G M Mol
Journal:  Drug Saf       Date:  2013-09       Impact factor: 5.606

2.  The impact of direct healthcare professional communication on prescribing practice in the UK hospital setting: an interrupted time series analysis.

Authors:  Sarah K Thomas; James Hodson; Graham McIlroy; Annjeet Dhami; Jamie J Coleman
Journal:  Drug Saf       Date:  2013-07       Impact factor: 5.606

3.  Assessment of the impact of scheduled postmarketing safety summary analyses on regulatory actions.

Authors:  S Sekine; E E Pinnow; E Wu; R Kurtzig; M Hall; G J Dal Pan
Journal:  Clin Pharmacol Ther       Date:  2016-03-31       Impact factor: 6.875

4.  [Effect of the direct healthcare professional communication on citalopram and escitalopram drug utilization for inpatient treatment of anxiety disorders].

Authors:  Ursula Köberle; Renate Grohmann; Michael Belz; Waldemar Greil; Detlef Degner
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2022-09-28       Impact factor: 1.595

5.  The past, present and perhaps future of pharmacovigilance: homage to Folke Sjoqvist.

Authors:  Nicholas Moore
Journal:  Eur J Clin Pharmacol       Date:  2013-05-03       Impact factor: 2.953

6.  The increase in prescriptions of bisphosphonates and the incidence proportion of osteonecrosis of the jaw after risk communication activities in Japan: a hospital-based cohort study.

Authors:  Eriko Sumi; Toru Yamazaki; Shiro Tanaka; Keiichi Yamamoto; Takeo Nakayama; Kazuhisa Bessho; Masayuki Yokode
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-01-08       Impact factor: 2.890

7.  Prescription behavior for gastroprotective drugs in new users as a result of communications regarding clopidogrel - proton pump inhibitor interaction.

Authors:  Willemien J Kruik-Kollöffel; Job van der Palen; H Joost Kruik; Myrthe P P van Herk-Sukel; Kris L L Movig
Journal:  Pharmacol Res Perspect       Date:  2016-07-18

8.  Factors Influencing the Use of a Mobile App for Reporting Adverse Drug Reactions and Receiving Safety Information: A Qualitative Study.

Authors:  Sieta T de Vries; Lisa Wong; Alastair Sutcliffe; François Houÿez; Carmen Lasheras Ruiz; Peter G M Mol
Journal:  Drug Saf       Date:  2017-05       Impact factor: 5.606

9.  Safety Communication Tools and Healthcare Professionals' Awareness of Specific Drug Safety Issues in Europe: A Survey Study.

Authors:  Sieta T de Vries; Maartje J M van der Sar; Anna Marie Coleman; Yvette Escudero; Alfonso Rodríguez Pascual; Miguel-Ángel Maciá Martínez; Amelia Cupelli; Ilaria Baldelli; Ivana Šipić; Adriana Andrić; Line Michan; Petra Denig; Peter G M Mol
Journal:  Drug Saf       Date:  2018-07       Impact factor: 5.606

10.  Are monitoring instructions provided in direct healthcare professional communications (DHPCs) of sufficient quality? A retrospective analysis of DHPCs sent out between 2007 and 2018.

Authors:  Maja-Marie Grønfeldt Højer; Marie Louise De Bruin; Arnela Boskovic; Christine Erikstrup Hallgreen
Journal:  BMJ Open       Date:  2020-05-11       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.